NEW YORK, Nov. 23 (GenomeWeb News) - Charles River Laboratories and France-based GenOway will speed availability of genetically modified research models to their customers in Europe, the companies said this week.
Under the terms of the three-year agreement, Charles River Labs will market and promote GenOway's processes for developing research models, which include gene-expression and gene-inactivation techniques for mouse and rat models, the companies said.
Charles River Labs, which is based in Wilmington, Mass., said that it will market GenOway's technology to clients of its European Transgenic Services business. GenOway is based in Lyon.
The companies estimate that the agreement will result in a 45-percent shorter development time for such models while using the same budget as classical models, according to a statement.
Financial terms of the deal were not disclosed.